BVEFX
Price
$21.15
Change
+$0.15 (+0.71%)
Updated
Jun 27 closing price
Net Assets
96.06M
DODGX
Price
$270.23
Change
+$1.63 (+0.61%)
Updated
Jun 27 closing price
Net Assets
113.58B
Interact to see
Advertisement

BVEFX vs DODGX

Header iconBVEFX vs DODGX Comparison
Open Charts BVEFX vs DODGXBanner chart's image
Becker Value Equity Retail
Price$21.15
Change+$0.15 (+0.71%)
VolumeN/A
Net Assets96.06M
Dodge & Cox Stock I
Price$270.23
Change+$1.63 (+0.61%)
VolumeN/A
Net Assets113.58B
BVEFX vs DODGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BVEFX vs. DODGX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVEFX is a Buy and DODGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 114B vs. BVEFX (96.1M). DODGX pays higher dividends than BVEFX: DODGX (1.40) vs BVEFX (1.20). BVEFX was incepted earlier than DODGX: BVEFX (22 years) vs DODGX (61 years). BVEFX (1.04) is less costly to investors than DODGX (0.51). BVEFX is a more actively managed with annual turnover of: 20.00 vs. DODGX (15.00). BVEFX (2500) and DODGX (2500) have matching initial minimum investment requirements. BVEFX annual gain was more profitable for investors over the last year : 7.91 vs. DODGX (7.01). DODGX return over 5 years is better than : 82.92 vs. BVEFX (45.18).
BVEFXDODGXBVEFX / DODGX
Total Expense Ratio0.780.51153%
Annual Report Gross Expense Ratio1.040.51204%
Fund Existence22 years61 years-
Gain YTD6.6035.954111%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets96.1M114B0%
Annual Yield % from dividends1.201.4086%
Returns for 1 year7.917.01113%
Returns for 3 years13.6428.7048%
Returns for 5 years45.1882.9254%
Returns for 10 years25.9460.7043%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBIO0.750.04
+6.34%
iBio
CATX3.760.14
+3.87%
Perspective Therapeutics
AER117.241.51
+1.30%
Aercap Holdings NV
PBYI3.330.02
+0.60%
Puma Biotechnology
BTE1.83-0.01
-0.54%
Baytex Energy Corp